Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68071-2522

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68071-2522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2522 1)

This is a description of a medication called "Metoprolol Succinate 50mg*". It is manufactured by NuCare Pharmaceuticals and comes in a pack of 100 extended-release tablets. Each tablet contains Metoprolol Succinate, with 47.5mg being equivalent to Metoprolol Tartrate 50mg. The label urges users to contact their doctor if any side effects are reported. The medication should be kept out of reach of children and stored at a controlled temperature of 68-77°F.*

FDA Label Image

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 01)

FDA Label Image

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 02)

Results for subgroups in MERIT-HF study, comparing the effectiveness of metoprolol versus placebo in heart failure patients. The table displays data on Time to First Event and relative risk with 95% confidence intervals for different subgroups, such as those based in geographical location, age, gender, baseline characteristics, NYHA class, EF, history of MI, and HR. Some data is missing or unreadable in this transcription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.